Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Richard L. Morrow"'
Autor:
Jean Damascene Makuza, Dahn Jeong, Stanley Wong, Mawuena Binka, Prince Asumadu Adu, Héctor Alexander Velásquez García, Richard L. Morrow, Georgine Cua, Amanda Yu, Maria Alvarez, Sofia Bartlett, Hin Hin Ko, Eric M. Yoshida, Alnoor Ramji, Mel Krajden, Naveed Zafar Janjua
Publikováno v:
The Lancet Regional Health. Americas, Vol 36, Iss , Pp 100826- (2024)
Summary: Background: We evaluated the association of hepatitis B virus (HBV) treatment with all-cause, and liver-related mortality among individuals with HBV and cirrhosis in British Columbia (BC), Canada. Methods: This analysis included people diagn
Externí odkaz:
https://doaj.org/article/645343e1635241beb792a883b3708884
Autor:
Richard L. Morrow, Mawuena Binka, Julia Li, Mike Irvine, Sofia R. Bartlett, Stanley Wong, Dahn Jeong, Jean Damascene Makuza, Jason Wong, Amanda Yu, Mel Krajden, Naveed Zafar Janjua
Publikováno v:
Viruses, Vol 16, Iss 5, p 655 (2024)
We investigated the impacts of the COVID-19 pandemic on hepatitis C (HCV) treatment initiation, including by birth cohort and injection drug use status, in British Columbia (BC), Canada. Using population data from the BC COVID-19 Cohort, we conducted
Externí odkaz:
https://doaj.org/article/ed0677ad96d74e96ba910d9fb2bb3113
Autor:
Barbara Mintzes, Ellen Reynolds, Priya Bahri, Lucy T Perry, Alice L Bhasale, Richard L Morrow, Colin R Dormuth
Publikováno v:
Expert Opinion on Drug Safety. 21:1269-1273
Many adverse effects of medicines only become known after approval, prompting regulatory agencies to issue post-market safety advisories to support safer care. Our team evaluated advisories issued by national regulators in Australia, Canada, Denmark,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8631aed5c90548efd4ce7cdb8a9b420a
https://doi.org/10.1080/14740338.2022.2134342
https://doi.org/10.1080/14740338.2022.2134342
Autor:
Richard L. Morrow, Barbara Mintzes, Garry Gray, Michael R. Law, Scott Garrison, Colin R. Dormuth
Publikováno v:
Clinical Therapeutics. 44:374-388
Approximately 40% of randomized controlled trials are not published, leading to publication bias and less informed clinical decision-making. Qualitative interviews were conducted to understand whether and how industry sponsors of clinical trials of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444a5835af062716e78d6e18b811cebd
https://doi.org/10.1016/j.clinthera.2021.11.019
https://doi.org/10.1016/j.clinthera.2021.11.019
Autor:
Richard L. Morrow, Barbara Mintzes, Garry Gray, Michael R. Law, Scott Garrison, Colin R. Dormuth
Publikováno v:
British journal of clinical pharmacologyREFERENCES.
This study aims to understand factors contributing to nonpublication and publication bias in clinical trials in Canada.Qualitative interviews were conducted between March 2019 and April 2021 with 34 participants from the Canadian provinces of Alberta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96a1a845306f0988f5982def60dcaabc
https://pubmed.ncbi.nlm.nih.gov/36268743
https://pubmed.ncbi.nlm.nih.gov/36268743
Autor:
Richard L Morrow, Barbara Mintzes, Garry Gray, Michael R Law, Scott Garrison, Colin R Dormuth
Publikováno v:
BMJ Open. 13:e068221
ObjectiveTo understand how the experiences and views of trial participants, trial investigators and others connected to clinical trial research relate to whether researchers have a duty to participants to publicly report research findings.DesignQuali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32ddbc0eb789daf857039ed819002961
https://doi.org/10.1136/bmjopen-2022-068221
https://doi.org/10.1136/bmjopen-2022-068221
Publikováno v:
Journal of Population Therapeutics & Clinical Pharmacology. 27:e32-e55
Oral anticoagulants (OACs) are high-priority medications, frequently used with clinically important benefit and serious harm. Our objective was to compare the safety and effectiveness of direct-acting oral anticoagulants (DOACs) versus warfarin in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c46812e2ffa0b7973fa23d7c7ba2a917
https://doi.org/10.15586/jptcp.v27i2.662
https://doi.org/10.15586/jptcp.v27i2.662
Publikováno v:
Pharmaceutical Medicine. 34:135-140
The US Food and Drug Administration (FDA) and other major regulators regularly issue safety advisories about licensed drugs with new adverse effects that have been documented through observational studies, clinical trials, and spontaneously reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2b663be29dee8fd46b6dc07ff1b55a
https://doi.org/10.1007/s40290-020-00329-w
https://doi.org/10.1007/s40290-020-00329-w
Publikováno v:
CMAJ Open. 7:E484-E491
Background The College of Physicians and Surgeons of British Columbia introduced opioid prescribing standards and guidelines in mid-2016 in British Columbia. We evaluated impacts of the standards and guidelines on health outcomes. Methods We conducte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44417ab895e4f31ac1fb4f371531b05e
https://doi.org/10.9778/cmajo.20190003
https://doi.org/10.9778/cmajo.20190003
Publikováno v:
CMAJ Open
BACKGROUND: The College of Physicians and Surgeons of British Columbia introduced opioid prescribing standards and guidelines in mid-2016 in British Columbia. We evaluated impacts of the standards and guidelines on health outcomes. METHODS: We conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0882dead5455db272b5a58fe3d051df3
https://europepmc.org/articles/PMC7759098/
https://europepmc.org/articles/PMC7759098/
